Growth Metrics

INVO Fertility (IVF) Gains from Equity Investments (2021 - 2023)

INVO Fertility (IVF) has disclosed Gains from Equity Investments for 3 consecutive years, with $8163.0 as the latest value for Q3 2023.

  • Quarterly Gains from Equity Investments fell 61.98% to $8163.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $22103.0 through Sep 2023, down 94.79% year-over-year, with the annual reading at $200558.0 for FY2022, 38.77% down from the prior year.
  • Gains from Equity Investments for Q3 2023 was $8163.0 at INVO Fertility, up from -$3788.0 in the prior quarter.
  • The five-year high for Gains from Equity Investments was $214050.0 in Q4 2021, with the low at -$10007.0 in Q4 2022.
  • Average Gains from Equity Investments over 3 years is $62245.6, with a median of $27735.0 recorded in 2023.
  • The sharpest move saw Gains from Equity Investments tumbled 104.68% in 2022, then crashed 61.0% in 2023.
  • Over 3 years, Gains from Equity Investments stood at $214050.0 in 2021, then crashed by 104.68% to -$10007.0 in 2022, then surged by 181.57% to $8163.0 in 2023.
  • According to Business Quant data, Gains from Equity Investments over the past three periods came in at $8163.0, -$3788.0, and $27735.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.